NCT06462092 2025-09-29Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast CancerGuangzhou Medical UniversityPhase 1/2 Recruiting34 enrolled